A Study To Investigate The Effects Of End Stage Renal Disease And Hemodialysis On The Pharmacokinetics Of Ropinirole
NCT00422994
·
clinicaltrials.gov ↗
PHASE1
Phase
COMPLETED
Status
48
Enrollment
INDUSTRY
Sponsor class
Conditions
Restless Legs Syndrome
Interventions
DRUG:
ropinirole dosing for up to 28 days
Sponsor
GlaxoSmithKline